Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (461-470 of 688) with videos related to

Pageof 69
Sort By:
European Heart Journal|September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
Blood Pressure|April 25, 2007
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular riskMichael A Weber, George L Bakris, Björn Dahlöf, et al.
Circulation|September 29, 2004
Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery diseaseMark A Hlatky, Derek B Boothroyd, Kathryn A Melsop, et al.
European Heart Journal|September 12, 2012
Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiencyCarolyn S P Lam, Amil M Shah, Barry A Borlaug, et al.
Circulation|May 16, 2023
Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF TrialsKashvi Gupta, John A Spertus, Mary Birmingham, et al.
European Journal of Internal Medicine|October 21, 2023
The current best drug treatment for hypertensive heart failure with preserved ejection fractionAurora Rist, Kaja Sevre, Kristian Wachtell, et al.
BMJ Open|March 20, 2024
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trialsShweta Bansal, Maria E F Canziani, Rita Birne, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2021
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINEJoão Pedro Ferreira, John G Cleland, Carolyn S P Lam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSarah E Elzinga, Diana M Rigan, Crystal Pacut, et al.
European Journal of Heart Failure|March 7, 2014
Decongestion in acute heart failureRobert J Mentz, Keld Kjeldsen, Gian Paolo Rossi, et al.
Pageof 69

Showing results (461-470 of 688) with videos related to

Sort By:
Pageof 69
European Heart Journal|September 17, 2015
Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionScott D Solomon, Brian Claggett, Eldrin F Lewis, et al.
Blood Pressure|April 25, 2007
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular riskMichael A Weber, George L Bakris, Björn Dahlöf, et al.
Circulation|September 29, 2004
Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery diseaseMark A Hlatky, Derek B Boothroyd, Kathryn A Melsop, et al.
European Heart Journal|September 12, 2012
Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiencyCarolyn S P Lam, Amil M Shah, Barry A Borlaug, et al.
Circulation|May 16, 2023
Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF TrialsKashvi Gupta, John A Spertus, Mary Birmingham, et al.
European Journal of Internal Medicine|October 21, 2023
The current best drug treatment for hypertensive heart failure with preserved ejection fractionAurora Rist, Kaja Sevre, Kristian Wachtell, et al.
BMJ Open|March 20, 2024
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trialsShweta Bansal, Maria E F Canziani, Rita Birne, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 9, 2021
Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINEJoão Pedro Ferreira, John G Cleland, Carolyn S P Lam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentSarah E Elzinga, Diana M Rigan, Crystal Pacut, et al.
European Journal of Heart Failure|March 7, 2014
Decongestion in acute heart failureRobert J Mentz, Keld Kjeldsen, Gian Paolo Rossi, et al.
Pageof 69